A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Study to Investigate the Efficacy and Safety of SER120 Nasal Spray Formulations in Patients With Nocturia
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
New City |
| State: |
|
New York |
| Zip Code: |
|
10956 |
| Conditions: |
|
Nocturia |
| Purpose: |
|
The purpose of this study is to investigate the efficacy and safety of SER120 nasal spray
formulations in patients with nocturia for a total duration of 14 weeks.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Male and female 50 years or older
- Nocturia of 6 or more months duration averaging greater than 2 nocturic episode per
night
Exclusion Criteria:
- CHF
- Diabetis Insipidus
- Renal Insufficiency
- Hepatic Insufficiency
- Incontinence
- Illness requiring systemic steroids
- Malignancy within the past 5 years
- Sleep Apnea
- Nephrotic Syndrome
- Unexplained Pelvic Mass
- Urinary Bladder Neurological dysfunction
- Urinary Bladder Surgery or Radiotherapy
- Pregnant or Breast Feeding
|
| NCT ID: |
|
NCT01357356 |
| Primary Contact: |
|
N/A |
| Backup Contact: |
|
N/A |
| Location Contact: |
|
New City, New York 10956
United States
There is no listed contact information for this specific location.
Site Status: N/A |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 22, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|